These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 54681)

  • 1. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis.
    Cathcart ES; Idelson BA; Scheinberg MA; Couser WG
    Lancet; 1976 Jan; 1(7952):163-6. PubMed ID: 54681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis.
    Barron KS; Person DA; Brewer EJ; Beale MG; Robson AM
    J Pediatr; 1982 Jul; 101(1):137-41. PubMed ID: 7045314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methylprednisolone pulses in active lupus nephritis.
    Ponticelli C; Tarantino A; Pioltelli P; Invernizzi F
    Lancet; 1977 May; 1(8020):1063. PubMed ID: 67530
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylprednisolone pulse therapy for lupus nephritis: a followup study.
    Hoch S; Schur PH
    Clin Exp Rheumatol; 1984; 2(4):313-20. PubMed ID: 6335863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indication of methylprednisolone "pulse" therapy on lupus nephritis].
    Kinashi M
    Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1055-63. PubMed ID: 7161952
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.
    Kimberly RP; Lockshin MD; Sherman RL; McDougal JS; Inman RD; Christian CL
    Am J Med; 1981 Apr; 70(4):817-24. PubMed ID: 6971057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of diffuse proliferative lupoid nephritis with high dosages of intravenous methylprednisone. Analysis of 9 cases].
    Spizzirri FD; Rentería MS; Rahman RC; Bibiloni NN; Gallo G
    Bol Med Hosp Infant Mex; 1984 Jul; 41(7):377-82. PubMed ID: 6477701
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone.
    Ponticelli C; Zucchelli P; Banfi G; Cagnoli L; Scalia P; Pasquali S; Imbasciati E
    Q J Med; 1982; 51(201):16-24. PubMed ID: 7111671
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis].
    Ivanova MM; Solov'ev SK; Speranskiĭ AI; Nasonov EL
    Ter Arkh; 1983; 55(7):114-9. PubMed ID: 6623376
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.
    Garin EH; Sleasman JW; Richard GA; Iravani AA; Fennell RS
    Eur J Pediatr; 1986 Oct; 145(5):380-3. PubMed ID: 3792382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
    Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis.
    Li M; Wang Y; Qiu Q; Wei R; Gao Y; Zhang L; Wang Y; Zhang X; Chen X
    J Clin Apher; 2016 Aug; 31(4):375-80. PubMed ID: 26018932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney in lupus erythematosus.
    Rothfield NF
    Contrib Nephrol; 1977; 7():128-42. PubMed ID: 330103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.
    Mackay IR; Robson G; Chan D
    Australas Ann Med; 1970 May; 19(2):123-30. PubMed ID: 4194493
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.
    Lin CY; Hsu HC; Chiang H
    Nephron; 1989; 53(4):303-10. PubMed ID: 2481240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history and response to therapy of lupus nephritis.
    Ginzler EM; Bollet AJ; Friedman EA
    Annu Rev Med; 1980; 31():463-87. PubMed ID: 6994624
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of lupus nephritis by methyl prednisolone pulse therapy.
    Dosa S; Cairns SA; Lawler W; Mallick NP; Slotki IN
    Postgrad Med J; 1978 Sep; 54(635):628-32. PubMed ID: 724583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term efficacy of high-dose intravenous methylprednisolone pulses in active lupus nephritis. A 21-month prospective study.
    Bertoni M; Brugnolo F; Bertoni E; Salvadori M; Romagnani S; Emmi L
    Scand J Rheumatol; 1994; 23(2):82-6. PubMed ID: 8165443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.